Oxidative Medicine and Cellular Longevity / 2018 / Article / Tab 5

Research Article

Citrus aurantium Naringenin Prevents Osteosarcoma Progression and Recurrence in the Patients Who Underwent Osteosarcoma Surgery by Improving Antioxidant Capability

Table 5

Osteosarcoma volume and metastasis after average two-year follow-up.

Naringenin group ()Control group () values

Osteosarcoma volume106.3 ± 92.7 c.c.225.8 ± 141.4 c.c.0.01
Pulmonary metastasis, n (%)7 (15.6)9 (20.0)0.58
Other bone metastasis, n (%)5 (11.1)6 (13.3)0.75

Note: 2 died in naringenin group and 3 died in control group after a two-year follow-up. via a control group.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.